APCDD1 Gene Hypotrichosis Type 1 Genetic Test in UAE | 2,800 AED | 2026 DHA Guidelines

تحليل جين APCDD1 لتشخيص نقص الشعر الخلقي من النوع الأول في الإمارات | 2,800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary & Clinical Assurance

✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.

✓ Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Transport & VIP Mobile Phlebotomy.

✓ Clinical Guidance: Telephonic Post‑Test Consultation by DHA‑Licensed Genetic Counsellors to interpret your results.

✓ Insurance: Direct Billing Verification — WhatsApp +971 54 548 8731.

✓ ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة تحليلية معتمدة بمعيار الآيزو 9001:2015.

✓ خدمات لوجستية متميزة: خدمة سحب عينات منزلية بمستوى المستشفيات مع نقل مبرد معتمد بشهادة الآيزو وخدمة الفصد المتنقل الفاخر.

✓ الإرشاد السريري: استشارة هاتفية بعد الفحص يقدمها مستشارو جينات مرخصون من هيئة الصحة بدبي.

✓ التأمين: التحقق المباشر من التغطية التأمينية عبر واتساب: 971 54 548 8731+.

Test Overview & Regulatory Positioning

The APCDD1 Gene Hypotrichosis Type 1 Genetic Test identifies pathogenic mutations in the APCDD1 gene linked to autosomal dominant hypotrichosis simplex. Performed via next‑generation sequencing, it provides a comprehensive genetic diagnosis for hair loss disorders that often present in early childhood.

يتيح تحليل جين APCDD1 باستخدام تقنية التسلسل من الجيل التالي تشخيصاً دقيقاً للطفرات المسببة لنقص الشعر الخلقي البسيط من النوع الأول، وهو اضطراب صبغي جسدي سائد يظهر غالباً في مرحلة الطفولة المبكرة.

Feature	Our APCDD1 NGS Test	Single‑Gene Sanger Sequencing
Precision & Coverage	Full gene sequencing with copy‑number variant detection (99.9% analytical sensitivity)	Only targeted point mutations; limited CNV detection
Methodology	Next‑Generation Sequencing (Illumina platform, validated per CAP/CLIA)	Capillary electrophoresis‑based Sanger sequencing
Turnaround Time	3 – 4 Weeks with comprehensive clinical report	6 – 8 Weeks; limited variant interpretation

Indicated Clinical Specialties: Dermatologist (diagnosis & hair disorder management), Clinical Geneticist (genetic counselling, pedigree analysis, result interpretation), Medical Geneticist (advanced variant annotation).

Physician Insight & Safety Protocol

“A genetic result is never a standalone verdict. I always emphasise that this APCDD1 test must be interpreted alongside a detailed dermatological exam and three‑generation pedigree. Even a pathogenic mutation may show variable expression, so we rely on clinical correlation before making any diagnosis or treatment plan.”
— Dr. PRABHAKAR REDDY, DHA License 61713011

⚠️ Medication Warning: Do not discontinue any prescribed medication without consulting your doctor. The test result does not constitute a treatment order.

Exclusion Criteria & Emergency Red Flags

Active febrile illness or systemic infection within 72 hours of sample collection.
Inability to provide informed consent or cooperate with venipuncture/ FTA card collection.
Known severe adverse reaction to phlebotomy (e.g., vasovagal syncope with injury risk) — pre‑sedation not provided.
Seek immediate medical attention if you experience dizziness, fainting, rapid swelling at the puncture site, or shortness of breath after collection.

Patient FAQ & Clinical Guidance

Q: What is this APCDD1 gene test used for?

Snippet: This NGS test analyzes the APCDD1 gene to detect mutations causing hereditary hypotrichosis simplex type 1, a rare hair loss condition.

It is indicated for patients with sparse or absent scalp hair from early childhood, those with a positive family history, and for carrier testing in at‑risk relatives. The report identifies pathogenic variants and clarifies inheritance risk.

الملخص: يحلل هذا الفحص باستخدام التسلسل من الجيل التالي جين APCDD1 للكشف عن الطفرات المسببة لنقص الشعر الخلقي البسيط من النوع الأول، وهو اضطراب نادر يؤدي إلى ترقق الشعر أو غيابه.

Q: How is the sample collected and is a needle required?

Snippet: Sample collection can be done via a simple blood draw or a painless finger prick for an FTA card, performed by a certified phlebotomist.

For whole blood, a small volume (3–5 mL) is drawn from a vein in the arm using a sterile technique. Alternatively, a single drop of blood on an FTA card is sufficient for DNA extraction and is especially convenient for paediatric patients. Home collection is available 8 AM – 11 PM daily.

الملخص: يمكن جمع العينة عبر سحب دم وريدي بسيط أو وخز الإصبع بلا ألم لوضع قطرة دم على بطاقة FTA، ويقوم بذلك فني معتمد.

Q: How long do the results take and what will the report include?

Snippet: Results are available in 3 to 4 weeks, including a comprehensive report with mutation analysis and clinical interpretation by DHA‑licensed geneticists.

The report details the identified variant (with HGVS nomenclature), its pathogenicity classification (ACMG 2026 criteria), and a correlated risk statement. Telephonic post‑test counselling is included to explain the findings and any further clinical steps.

الملخص: تصدر النتائج خلال 3 إلى 4 أسابيع، وتتضمن تقريراً شاملاً مع تحليل الطفرات وتفسير سريري من قبل متخصصين في الجينات الوراثية مرخصين من هيئة الصحة بدبي.

UAE Regulatory Compliance & Quality Assurance

Licensed under DHA Facility Permit 9834453 and compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87) on medical validity and patient data protection.
Strict adherence to CDS Law 2026 for minors: mandatory parental/guardian consent and genetic counselling before testing individuals under 18.
Operates under the UAE Personal Data Protection Law (PDPL) — your genetic data is encrypted, stored securely, and never shared without explicit consent.
Accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) for laboratory quality management systems.

دعم ثنائي اللغة متاح